| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Dec 1, 2025 | Dec 3, 2025 | ENTEGRIS INC | Chair | Sell | 15.0 | -57,570 | -15.84% | ✓ | $4.4M |
| Apr 5, 2025 | Apr 8, 2025 | ENTEGRIS INC | CEO | Sell | 40.0 | -4,619 | -1.49% | ✗ | $302K |
| Feb 20, 2025 | Feb 24, 2025 | ENTEGRIS INC | CEO | Sell | 37.5 | -12,932 | -4.80% | ✗ | $1.4M |
| Feb 19, 2025 | Feb 21, 2025 | ENTEGRIS INC | CEO | Sell | 85.0 | +6,544 | 2.49% | ✗ | $661.7K |
| Jul 3, 2024 | Jul 8, 2024 | ENTEGRIS INC | CEO | Sell | 23.8 | -27,044 | -9.32% | ✓ | $3.8M |
| Feb 16, 2024 | Feb 21, 2024 | ENTEGRIS INC | CEO | Sell | 37.5 | -4,329 | -1.89% | ✗ | $3.4M |
| Aug 15, 2023 | Aug 17, 2023 | ENTEGRIS INC | CEO | Sell | 20.0 | -9,357 | -3.92% | ✗ | $897.1K |
| Feb 17, 2023 | Feb 21, 2023 | ENTEGRIS INC | CEO | Sell | 37.5 | -14,126 | -5.59% | ✗ | $1.2M |
| Feb 13, 2023 | Feb 15, 2023 | ENTEGRIS INC | CEO | Sell | 90.0 | +10,949 | 4.53% | ✗ | $741.3K |
| Aug 26, 2022 | Aug 29, 2022 | HARVARD BIOSCIENCE INC | Director | Buy | 78.8 | +9,291 | 2.02% | ✗ | $31.7K |
| Aug 24, 2022 | Aug 26, 2022 | HARVARD BIOSCIENCE INC | Director | Buy | 90.0 | +25,535 | 5.89% | ✗ | $83.4K |
| Aug 22, 2022 | Aug 24, 2022 | HARVARD BIOSCIENCE INC | Director | Buy | 83.8 | +13,857 | 3.30% | ✗ | $44.4K |
| Aug 18, 2022 | Aug 22, 2022 | HARVARD BIOSCIENCE INC | Director | Buy | 83.8 | +10,759 | 2.63% | ✗ | $35.2K |
| Aug 15, 2022 | Aug 17, 2022 | ENTEGRIS INC | CEO | Sell | 20.0 | -9,357 | -4.68% | ✗ | $986.1K |
| Feb 18, 2022 | Feb 23, 2022 | ENTEGRIS INC | CEO | Sell | 37.5 | -15,043 | -7.01% | ✗ | $2M |
| Feb 11, 2022 | Feb 15, 2022 | ENTEGRIS INC | CEO | Sell | 95.0 | +13,367 | 6.64% | ✗ | $1.3M |
| Aug 11, 2021 | Aug 13, 2021 | ENTEGRIS INC | CEO | Sell | 17.5 | -23,710 | -100.00% | ✗ | $2.8M |
| Aug 9, 2021 | Aug 11, 2021 | ENTEGRIS INC | CEO | Sell | 15.0 | -139,806 | -41.41% | ✗ | $16.9M |
| Aug 4, 2021 | Aug 6, 2021 | ENTEGRIS INC | CEO | Sell | 16.3 | -56,178 | -14.27% | ✗ | $7M |
| Apr 12, 2021 | Apr 14, 2021 | ENTEGRIS INC | CEO | Sell | 2.5 | -300,000 | -43.24% | ✓ | $35.6M |
| Apr 5, 2021 | Apr 7, 2021 | ENTEGRIS INC | CEO | Sell | 2.5 | -300,444 | -30.22% | ✓ | $36.3M |
| Feb 19, 2021 | Feb 23, 2021 | ENTEGRIS INC | CEO | Sell | 40.0 | -3,737 | -0.54% | ✗ | $2.9M |
| Jul 30, 2020 | Aug 3, 2020 | ENTEGRIS INC | CEO | Sell | 15.0 | -257,928 | -27.86% | ✗ | $18.3M |
| Jul 24, 2020 | Jul 28, 2020 | ENTEGRIS INC | CEO | Sell | 7.5 | -170,988 | -21.47% | ✓ | $11.7M |
| Feb 19, 2020 | Feb 21, 2020 | ENTEGRIS INC | CEO | Sell | 17.5 | -22,255 | -3.44% | ✗ | $1.3M |
| Feb 18, 2020 | Feb 20, 2020 | ENTEGRIS INC | CEO | Sell | 90.0 | +21,517 | 3.44% | ✗ | $967.1K |
| Nov 8, 2019 | Nov 13, 2019 | HARVARD BIOSCIENCE INC | Director | Buy | 95.0 | +36,150 | 16.01% | ✗ | $92.7K |
| Sep 11, 2019 | Sep 13, 2019 | HARVARD BIOSCIENCE INC | Director | Buy | 95.0 | +34,259 | 17.89% | ✗ | $104.5K |
| Feb 25, 2019 | Feb 26, 2019 | ENTEGRIS INC | CEO | Sell | 95.0 | +34,170 | 6.09% | ✗ | $1M |
| Feb 19, 2019 | Feb 21, 2019 | ENTEGRIS INC | CEO | Sell | 20.0 | -24,977 | -4.26% | ✗ | $858.2K |
| Feb 20, 2018 | Feb 22, 2018 | ENTEGRIS INC | CEO | Sell | 15.0 | -535,690 | -15.28% | ✗ | $18M |
| Feb 19, 2018 | Feb 21, 2018 | ENTEGRIS INC | CEO | Sell | 20.0 | -27,861 | -5.29% | ✗ | $920.8K |
| Feb 12, 2018 | Feb 14, 2018 | ENTEGRIS INC | CEO | Sell | 97.5 | +74,705 | 16.52% | ✗ | $740.1K |
| Feb 19, 2017 | Feb 22, 2017 | ENTEGRIS INC | CEO | Sell | 20.0 | -24,617 | -5.16% | ✗ | $540.3K |
| Aug 1, 2016 | Aug 1, 2016 | ENTEGRIS INC | CEO | Sell | 17.5 | -100,255 | -10.64% | ✗ | $1.7M |